Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Mediated Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109369638B details a green, high-yield synthesis of dasatinib intermediates using heteropolyacid catalysis, offering significant cost reduction in API manufacturing.
Novel solid-phase synthesis of Teixobactin analogs via copper-mediated cyclization. Reduces steps and cost for antibiotic manufacturing.
Patent CN109503568A details a high-yield Dasatinib synthesis using ionic liquids and copper catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.